Filing Details
- Accession Number:
- 0001753926-24-000518
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-03-12 16:05:51
- Reporting Period:
- 2024-02-21
- Accepted Time:
- 2024-03-12 16:05:51
- Original Submission Date:
- 2024-02-21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1919246 | Chromocell Therapeutics Corp | CHRO | () | 4/A |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1679440 | M Ezra Friedberg | C/O Chromocell Therapeutics Corporation 4400 Route 9 South, Suite 1000 Freehold NJ 07728 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-21 | 16,667 | $6.00 | 545,721 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This Form 4/A is being filed to include the purchase of 16,667 shares of the Issuer's common stock (the "Common Stock") in the Issuer's initial public offering, in addition to the securities originally reported on the Form 4 filed by the reporting person on February 21, 2024.